A Cluster Package Intervention to Promote an Evidence-based Use of PSA-tests in General Practice
Recruiting
N/A
Interventional Study
Prostate Cancer
Evidence Based Medicine
Prostate Specific Antigen
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Sex
- Any
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 50 (estimated)
- Sponsor
- University of Copenhagen · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
It is widely acknowledged that prostate specific antigen (PSA) testing can lead to false-positives, overdiagnosis and overtreatment of prostate cancer. The current national clinical guidelines only recommend the test to a small group of patients and does not recommend neither systematic nor opportunistic screening for prostate cancer with the test.
The aim of this cluster randomized trial is to e…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Quality clusters with a cluster coordinator
* Quality clusters willing to participate in a cluster meeting with PSA as a theme in 2025.
Exclusion Criteria:
* Quality clusters who already planned their cluster meetings in 2025.
* Quality clusters unwilling to await allocation…
Contacts